Ref ID: 18349
Author:
Sara J.Blosser, Sven D.Willger, Robert A. Cramer Jr
Author address:
Department
of Immunology & Infectious Diseases, Montana State University, Bozeman, Montana, USA sara.wezensky@msu.montana.edu
Full conference title:
Asperfest 8
Abstract:
Deletion of the transcription factor SrbA results in complete growth inhibition under hypoxic conditions, avirulence in a murine model of Invasive
Aspergillosis (IA), and increased sensitivity of A. fumigatus to triazoles. The purpose of this study is to investigate the mechanism and role of SrbA in
mediating azole resistance. Azole drugs target ergosterol biosynthesis as their mechanism of action, and are the drug class of choice for treatment of IA.
Erg11 (cyp51), the target of triazoles, is a 14-demethylase, and two functional copies (A/B) are encoded in the A. fumigatus genome. Transcript analysis
shows down-regulation of Erg11A in the SrbA mutant, delta-srbA, suggesting regulation by this transcription factor. Induction of Erg11A in delta-srbA
by regulatable promoter replacement restores wild-type levels of Erg11A, and ameliorates the azole sensitivity phenotype observed in delta-srbA.
Repression of this construct restores azole sensitivity, demonstrating that Erg11A repression is partially or wholly responsible for the delta-srbA-azole
phenotype. As SrbA appears to regulate Erg11A and several other key enzymes in ergosterol biosynthesis, understanding the regulon of SrbA could be
vital in the development of higher-octane antifungals. Sterol intermediates in delta-srbA indicate a blockage in the Erg25 (C4-desaturase) enzymatic step,
which is compounded in the Erg11A-induced strain. Studies investigating the induction of Erg25A with Erg11A in the delta-srbA background are
underway.
Abstract Number: 27)
Conference Year: 2011
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a